Clinical Trial Detail

NCT ID NCT01940276
Title Abiraterone Race in Metastatic Castrate-resistant Prostate Cancer
Recruitment Completed
Gender male
Phase Phase II
Variant Requirements No
Sponsors Duke University
Indications

prostate adenocarcinoma

Therapies

Abiraterone + Prednisone

Age Groups: adult

No variant requirements are available.